Canary Stat™

Coming soon...

Focused Liquid Biopsy Panel

The Canary Stat™ Focused Liquid Biopsy Panel test

  • Cancer Types
  • Turnaround Time
    14 Business Days
  • Sample Types
    Peripheral Blood (all solid tumors)
Coming soon... Learn more

Test Features

Comprehensive Analysis

140 genes + 76 PGx + 340 MSI Markers + 41 HRR genes + 17 Intronic Fusions, TERT Promoter.

Compare with other companies

Comprehensive comparison of Canary diagnostic solutions with other companies' offerings

Note: Green Color highlighted text indicated test results where Canary has a differentiated advantage.

Test ResultsCanary Acuity™Canary Pulse™Top U.S. and Indian Competitors
Number of Genes Analyzed via NGS1091 (+637 Variants)468 (+37 Variants) 300-500
Therapeutic SNVs and InDels✓✓✓
Amplifications and Deletions✓✓✓
Fusions Genes✓✓✓
Tumor Mutational Burden (TMB)✓✓✓
Microsatellite Instability (MSI)✓✓✓
Homologous Recombination Deficiency (HRD)✓✓✓
Loss of Heterozygosity (LOH)✓✓✓
Comprehensive Proprietary Database of FDA Approved/Clinical Trial Drugs for Corresponding Biomarkers✓✓✓
Depiction of Cancer-Relevant Pathways✓✓✗
Germline Variants Affecting Drug Metabolism✓✓✗
Complete ACMG Oncology Germline Mutational Analysis✓✓✗
In Development
TCR Clonality✓✗✗
HLA Typing✓✓✗

Compare with Canary Tests

Comprehensive comparison of Canary diagnostic solutions

Test ResultsCanary Acuity™Canary Pulse™Canary Focus™
Number of Genes Analyzed via NGS1091 (+637 Variants)468 (+37 Variants)115+
Therapeutic SNVs and InDels✓✓✓
Amplifications and Deletions✓✓✓
Fusions Genes✓✓✓
Tumor Mutational Burden (TMB)✓✓✗
Microsatellite Instability (MSI)✓✓✓
Homologous Recombination Deficiency (HRD)✓✓✗
Loss of Heterozygosity (LOH)✓✓✓
Comprehensive Proprietary Database of FDA Approved/Clinical Trial Drugs for Corresponding Biomarkers✓✓✓
Depiction of Cancer-Relevant Pathways✓✓✗
Germline Variants Affecting Drug Metabolism✓✓✗
Complete ACMG Oncology Germline Mutational Analysis✓✓✗

Canary Stat™ Frequently Asked Questions